Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | ROIV | EXEL | ||
| Company | Ascendis Pharma ADR | Roivant Sciences Ltd | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 151.00 | 12.03 | 26.90 | ||
| High | 154.81 | 12.17 | 27.10 | ||
| Low | 149.26 | 11.85 | 26.65 | ||
| Last | 151.45 | 11.91 | 26.94 | ||
| Change | +2.57 | -0.09 | +0.12 | ||
| % Change | +1.73% | -0.75% | +0.45% | ||
| Volume | 560,261 | 3,083,201 | 1,122,490 | ||
| 20-Day Average Volume | 946,149 | 5,608,755 | 1,472,611 | ||
| Previous Close | 148.88 | 12.00 | 26.82 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 131.44 | 12.03 | 26.16 | ||
| 20-Day Raw Stochastic | 94.14% | 26.71% | 64.21% | ||
| 20-Day Relative Strength | 65.65% | 53.90% | 60.45% | ||
| Weighted Alpha | +41.55 | +19.07 | +30.57 | ||
| Today's Opinion | 8% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 8% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Buy | 64% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +33.78% since 09/12/24 | -1.69% since 09/12/24 | +2.09% since 09/12/24 | ||
| Low | 114.53 on 09/13/24 | 11.81 on 09/16/24 | 26.19 on 09/13/24 | ||
| High | 154.81 on 09/19/24 | 12.38 on 09/18/24 | 27.83 on 09/17/24 | ||
| 1-Month | |||||
| %Chg | +10.47% since 08/19/24 | +3.70% since 08/19/24 | +1.02% since 08/19/24 | ||
| Low | 111.09 on 09/12/24 | 11.41 on 08/20/24 | 25.12 on 09/09/24 | ||
| High | 154.81 on 09/19/24 | 13.06 on 09/09/24 | 27.83 on 09/17/24 | ||
| 3-Month | |||||
| %Chg | +23.59% since 06/18/24 | +9.92% since 06/18/24 | +24.58% since 06/18/24 | ||
| Low | 111.09 on 09/12/24 | 10.00 on 08/05/24 | 21.36 on 06/20/24 | ||
| High | 154.81 on 09/19/24 | 13.06 on 09/09/24 | 27.83 on 09/17/24 | ||
| 6-Month | |||||
| %Chg | +4.73% since 03/19/24 | +19.99% since 03/19/24 | +14.44% since 03/19/24 | ||
| Low | 111.09 on 09/12/24 | 9.80 on 03/20/24 | 20.14 on 05/29/24 | ||
| High | 156.84 on 04/10/24 | 13.06 on 09/09/24 | 27.83 on 09/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,669,430 | 8,864,664 | 8,131,825 | ||
| Shares Outstanding, K | 58,231 | 738,722 | 303,200 | ||
| Annual Sales | 288,670,000 | 124,800,000 | 1,830,210,000 | ||
| Annual Net Income | -521,070,000 | 4,348,930,000 | 207,770,000 | ||
| Last Quarter Sales | 38,770,000 | 55,130,000 | 637,180,000 | ||
| Last Quarter Net Income | -117,790,000 | 95,300,000 | 226,120,000 | ||
| 60-Month Beta | 0.63 | 1.25 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.05 on 09/03/24 | -0.18 on 08/08/24 | 0.84 on 08/06/24 | ||
| Latest Earnings Date | 11/05/24 | 11/11/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 24.21 | ||